Glen Baker

Title: Glen Baker: Innovator in Pharmaceutical Chemistry

Introduction

Glen Baker is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

One of Glen Baker's latest patents involves the creation of β-phenylethylidenehydrazine derivatives. This invention provides new derivatives, processes for preparing them, and their use as pharmaceutical compositions. The derivatives generally correspond to a specific general formula, showcasing their potential in medical applications. Another significant patent relates to pharmaceutical compositions containing N-propargylphentermine and its related analogs. This invention addresses the neuroprotective and anti-depressant activity of such compounds, offering therapeutic methods for treating neurodegeneration and depression.

Career Highlights

Throughout his career, Glen Baker has worked with various organizations, including C V Technologies Inc. and the University of Alberta. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Glen has collaborated with notable individuals in his field, including Ronald Coutts and Jacqueline J Shan. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Glen Baker's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in therapeutic applications.